-
-
-
-
-
-
-
LIXTE appoints Sidney Braun as CEO of Liora Technologies Europe subsidiary
-
-
-
-
-
-
-
LIXTE BIOTECHNOLOGY HOLDINGS, INC. REPORTS THAT ITS LEAD CLINICAL COMPOUND, LB-100, CAN KILL CANCER CELLS THROUGH HYPER-STIMULATION OF CELL PROLIFERATION SIGNALS IN PRE-CLINICAL MODELS
1,154,925 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

